Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro can reduce how well the oral contraceptive pill is absorbed, particularly during the first weeks of treatment and after each dose increase. The MHRA advises that women taking an oral contraceptive alongside tirzepatide should add a non-oral method of contraception — such as condoms — for the first four weeks of Mounjaro treatment and for four weeks following any dose increase. This is a prescription-only medicine, and your prescriber will discuss contraception with you as part of any clinical assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is whether Mounjaro makes the pill less effective. The short answer is: potentially yes, and the reason comes down to how tirzepatide works. Mounjaro slows gastric emptying, food and medicines move through the stomach more slowly than usual. For many drugs this makes little practical difference. For oral contraceptives, which rely on predictable gut absorption, the timing shift matters.
The concern is most pronounced at the start of treatment and again every time the dose steps up, because each increase intensifies the gastric-slowing effect before the body adjusts. NHS guidance, drawing on the Mounjaro Summary of Product Characteristics published on the electronic Medicines Compendium, advises adding a non-oral contraceptive method during those windows. A patch, injection, implant or IUD would not be subject to the same absorption issue. You can read the full patient-level guidance on the NHS tirzepatide medicines page.
This is not a theoretical risk invented by regulators out of caution, it reflects the known pharmacokinetics of drugs that delay gastric transit. If you want to understand in more depth how Mounjaro affects contraception across different methods and scenarios, we cover that in full detail separately. The practical precaution is straightforward once you know about it.
Non-oral hormonal contraceptives bypass the gut entirely and are therefore unaffected by tirzepatide's effect on gastric emptying. These include the contraceptive patch, the hormonal injection (Depo-Provera), the implant, the hormonal IUD (Mirena and similar), and the copper IUD. Condoms also work independently of Mounjaro.
If you already use one of these methods, there is no specific additional step required on account of starting Mounjaro. If you use the combined pill or the progestogen-only pill, the four-week back-up rule applies at treatment initiation and again at each dose increase through the titration schedule. The implant and Mounjaro page covers non-oral options in more detail.
NHS England's guidance on weight-management injections also flags this point in its wraparound care section, noting that healthcare teams should routinely discuss contraception before initiating tirzepatide. If your GP or another clinician is prescribing Mounjaro, they should cover this. If you transfer to a new provider mid-treatment, raise it explicitly at your first review.
Mounjaro is not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. This is a firm position based on the licensed SmPC, not a precautionary grey area. The MHRA advises using effective contraception throughout treatment and for a wash-out period before attempting pregnancy, the prescribing information specifies this period, and your prescriber or the Patient Information Leaflet will confirm the exact timeframe.
If your contraceptive plans change while you are on Mounjaro, the right step is a conversation with your prescriber before you stop using contraception rather than afterwards. The broader question of how Mounjaro interacts with contraception (including stopping, switching methods, and what to do if you think the pill may have failed) is covered separately.
For anyone managing weight during or after a pregnancy, treatment options and timing are best discussed with your GP or a specialist. An overview of how our clinical team works may help if you're deciding whether a private prescribing route is right for you.
Yes, and that applies in both directions. If your GP prescribes the contraceptive pill and you start Mounjaro privately, let them know. If your GP is managing Mounjaro on the NHS and you're using the pill, make sure that's on their radar too. Some patients also ask whether the metabolic changes from tirzepatide could have longer-term implications, and our page on whether taking Mounjaro can cause diabetes addresses that question directly. Clinical decisions about which contraceptive method to switch to, or whether to stay on the pill with a back-up method, are personal and depend on your full medical history.
The same logic applies when your Mounjaro dose increases, it is easy to forget that the four-week precaution restarts with each step up. If you are specifically using the combined or progestogen-only pill alongside treatment, our dedicated guidance on Mounjaro and the contraceptive pill explains the interaction, the back-up rules, and what to do at each dose change. Setting a calendar reminder for each dose change is a practical habit. If you have questions before or during treatment, our aftercare team is available seven days a week. For a fuller picture of what Mounjaro involves as a treatment, the Mounjaro treatment overview is a good place to start, and the NHS England guidance on weight-management injections sets out the official clinical advice on contraception in one place.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.